2-BBB Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Restart - Angel
- Investors
-
1
2-BBB General Information
Description
Developer of medicines designed to treat brain diseases. The company's medicines combine known disease targets and compounds with established drug delivery systems united with safe targeting technology, enabling patients with brain cancer and neuro-inflammatory diseases to get improved treatment.
Contact Information
Website
www.2-bbb.comCorporate Office
- Leiden Bio Science Park
- BioPartner Building 2, J.H. Oortweg 19
- 2333 CH Leiden
- Netherlands
Corporate Office
- Leiden Bio Science Park
- BioPartner Building 2, J.H. Oortweg 19
- 2333 CH Leiden
- Netherlands
2-BBB Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Restart - Angel | 01-Mar-2015 | Completed | Restart | |||
| 8. Bankruptcy: Admin/Reorg | 26-Jan-2015 | Completed | Bankruptcy: Admin/Reorg | |||
| 7. Later Stage VC (Series C) | 30-Jun-2014 | Completed | Clinical Trials - Phase 4 | |||
| 6. Later Stage VC | 25-Apr-2013 | Completed | Clinical Trials - Phase 4 | |||
| 5. Grant | 17-Apr-2012 | Completed | Clinical Trials - Phase 4 | |||
| 4. Grant | 29-Sep-2011 | Completed | Clinical Trials - Phase 4 | |||
| 3. Later Stage VC | 03-Feb-2011 | Completed | Clinical Trials - Phase 4 | |||
| 2. Early Stage VC (Series A) | 06-Jul-2007 | $5.38M | $5.38M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2003 | Completed | Startup |
2-BBB Patents
2-BBB Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2680820-A1 | Advanced active liposomal loading of poorly water-soluble substances | Active | 01-Mar-2011 | ||
| EP-2680820-B1 | Advanced active liposomal loading of poorly water-soluble substances | Active | 01-Mar-2011 | ||
| ES-2728225-T3 | Glutathione based drug delivery system | Active | 20-Feb-2009 | ||
| AU-2010216512-A1 | Glutathione-based drug delivery system | Active | 20-Feb-2009 | ||
| AU-2010216512-B2 | Glutathione-based drug delivery system | Inactive | 20-Feb-2009 | A61K31/704 |
2-BBB Signals
2-BBB Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Leiden University | University |
2-BBB Investments (1)
2-BBB’s most recent deal was a Joint Venture with EnhanX Biopharm. The deal was made on 01-Aug-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EnhanX Biopharm | 01-Aug-2017 | Joint Venture | Drug Discovery |
2-BBB FAQs
-
When was 2-BBB founded?
2-BBB was founded in 2003.
-
Where is 2-BBB headquartered?
2-BBB is headquartered in Leiden, Netherlands.
-
What is the size of 2-BBB?
2-BBB has 14 total employees.
-
What industry is 2-BBB in?
2-BBB’s primary industry is Drug Discovery.
-
Is 2-BBB a private or public company?
2-BBB is a Private company.
-
What is 2-BBB’s current revenue?
The current revenue for 2-BBB is .
-
How much funding has 2-BBB raised over time?
2-BBB has raised $27.6M.
-
Who are 2-BBB’s investors?
Leiden University has invested in 2-BBB.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process